ViewRay Inc. gets FDA approval to market its next-generation MRIdian Linac system

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell.

ViewRay Inc. (Nasdaq: VRAY) of Oakwood Village said it received clearance from the U.S. Food and Drug Administration to market the MRIdian Linac system, its next-generation MRI-guided radiation therapy system. FDA clearance (go here for the clearance document) of the MRIdian Linac “is a transformative milestone for ViewRay,” said Chris A. Raanes, president and CEO of ViewRay, in a statement.

Click here to read the complete article.

Originally published February 27, 2017.